title: Incidence of hemorrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients.
authors.affiliation: Retina Consultants of Alabama, Callahan Eye Foundation Hospital, Birmingham, Alabama 35233, USA. retinarounds@mac.com
authors.forename: John O
authors.initials: JO
authors.lastname: Mason
authors.forename: Paul A
authors.initials: PA
authors.lastname: Frederick
authors.forename: Michael G
authors.initials: MG
authors.lastname: Neimkin
authors.forename: Milton F
authors.initials: MF
authors.lastname: White
authors.forename: Richard M
authors.initials: RM
authors.lastname: Feist
authors.forename: Martin L
authors.initials: ML
authors.lastname: Thomley
authors.forename: Michael A
authors.initials: MA
authors.lastname: Albert